HB 1437 creates a Maryland income tax credit for long-term care insurance premiums paid by residents aged 45 or older. It allows taxpayers to claim a credit equal to 100% of eligible premiums (capped at $250 per year per insured person), covering the taxpayer, spouse, or certain family members. The credit is restricted to policies purchased after December 31, 2026, and cannot be claimed for individuals already covered before January 1, 2027, or for multiple taxpayers claiming the same person. The bill also requires annual reports to the legislature on credit usage and its impact on state medical assistance savings.
SB 707 amends Maryland's Mental Health Law to clarify the definition of "danger to the life or safety of the individual or of others" for involuntary admission and emergency evaluations. It specifies that this danger includes four key scenarios: causing bodily harm, engaging in conduct likely to result in criminal justice involvement, inability to meet basic needs (food, shelter, medical care) creating serious risk, or substantial deterioration in judgment preventing informed treatment decisions. The bill directly affects individuals with mental disorders who may be assessed for involuntary care, as well as healthcare providers making those determinations under the law. This definition replaces the current standard in Maryland Code, Section 10-601, and takes effect October 1, 2026.
HB 986 requires nursing license applicants (both new and those seeking endorsement) to provide evidence that their nursing education meets Maryland's standards, including official transcripts. It directly affects registered nurses and licensed practical nurses applying for or renewing licenses in Maryland. The bill adds a new provision (§ 8-316(a)(37)) allowing the State Board of Nursing to take disciplinary action - such as reprimands, probation, suspension, or revocation - against licensees who fail to complete required educational standards. This clarifies the Board’s authority to enforce education requirements, including investigating applicants' qualifications and taking disciplinary steps for non-compliance. The bill amends existing sections of Maryland’s Health Occupations law and takes effect October 1, 2026.
SB 562 allows pharmacists in Maryland to treat opioid use disorders using medication therapy under specific conditions. It repeals a requirement that prescribers (like doctors) must submit agreements to their health board and instead authorizes pharmacists to enter into prescriber-pharmacist agreements if they meet qualifications such as holding a Doctor of Pharmacy degree, completing required training, and registering with federal agencies. The law mandates that any treatment protocol requires pharmacists to check the Prescription Drug Monitoring Program before starting or changing medication. This change aims to expand access to medication-based treatment for opioid use disorders by enabling pharmacists to provide care in pharmacy settings.
SB 910 requires Maryland health insurers to reimburse patients for services provided by graduate-level clinical interns in counseling, social work, and psychology, under specific conditions. This affects insured individuals who receive these services and insurers who must cover them. Key conditions include services being provided at outpatient facilities, interns being enrolled in accredited graduate programs, working under direct supervision of a licensed professional, and billed by the supervising provider. The bill amends existing insurance codes (Sections 15-704, 15-707, and 15-714) to add these reimbursement requirements for each profession’s interns.
HB 1016 invalidates noncompete and conflict-of-interest clauses in employment contracts for certain employees if their employer relocates the majority of its employees or principal business location outside Maryland. It directly affects low-wage workers (earning ≤150% of state minimum wage), healthcare workers providing direct patient care (earning ≤$350,000 annually), and veterinary professionals. For high-earning healthcare workers ($350,000+), the bill allows limited 1-year noncompete restrictions within 10 miles of their prior workplace. The law takes effect October 1, 2026, and applies only to contracts signed after that date.
HB 737 requires health insurance plans (HMOs) to pay non-contracted healthcare providers at minimum rates: 140% of Medicare rates for trauma care, and 125% of the 2019 rate adjusted for inflation for other services. This affects independent doctors, hospitals, and clinics that treat HMO members but aren’t directly contracted with them. The law updates payment standards to better reflect current costs using Medicare’s inflation index, replacing older fixed-rate calculations. It ensures non-contracted providers receive fairer compensation for services rendered to HMO enrollees.
HB 1364 requires mammography centers in Maryland to include a specific notice about breast arterial calcification in patients' screening results letters, starting October 1, 2026. This applies to facilities performing mammography testing (like hospitals, clinics, or radiology practices), excluding federal VA facilities. The notice informs patients that arterial calcification - common but potentially linked to higher cardiovascular risk - should be discussed with their physician to assess heart health needs. It does not change existing federal requirements for breast density notices but adds this new patient awareness element to standard mammogram results.
HB 1384 requires Maryland’s Department of Health to select and contract with a single State Pharmacy Benefits Manager (SPBM) by July 1, 2028. This SPBM will administer pharmacy benefits for all Medicaid recipients, including those enrolled in managed care plans, which must contract with and use the SPBM for all pharmacy services after that date. The bill prohibits "spread pricing" (where managers profit from price differences between pharmacies and the program) and mandates transparent pricing for drug costs, rebates, and fees. It directly affects Medicaid beneficiaries, managed care organizations, and pharmacies by centralizing pharmacy benefit management under state oversight.
HB 1531 establishes the Maryland HEALTH Fund to help individuals cover costs for legally protected health care services under state law, especially where federal restrictions apply. The fund is financed by redirecting $20 million annually from abandoned property sales proceeds (starting fiscal year 2027), plus new premium taxes and portions of sales/use and property tax revenues. It directly assists Maryland residents needing life-saving treatments who face coverage gaps due to federal limitations. The bill creates a dedicated, nonlapsing fund to ensure consistent funding for these health care costs.
